StockData
Retension Pharmaceuticals, Inc. logo

Retension Pharmaceuticals, Inc. (RTSN) stock

RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 18, 2026
$13.89+2.48 (+21.74%)

Close on Nov 18, 2026Market cap $11.22MP/E –Yield –

Retension Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Retension Pharmaceuticals's total assets was $14.15M at Sep 30, 2026. For fiscal 2025 it was $21.45M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.45M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$14.15M–
Q4 FY2025Dec 31, 2025$21.45M–

More Retension Pharmaceuticals figures

See a number that looks wrong?